E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release

International Journal of Cancer

Volumn 123, Issue 8, 2008, Pages 1741-1750

  Aychek, Tegest ^a   Miller, Keren ^a   Sagi Assif, Orit ^a   Levy Nissenbaum, Orlev ^a   Israeli Amit, Mira ^a   Pasmanik Chor, Metsada ^a   Jacob Hirsch, Jasmin ^b   Amariglio, Ninette ^b   Rechavi, Gideon ^b   Witz, Isaac P ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Sheba Cancer Research Center   (Israel)

Author keywords

Colorectal carcinoma; E selectin; Extravasation; Gene expression; HMGB1; Metastasis; Selectin ligands

Indexed keywords

DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH MOBILITY GROUP B1 PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARCINOMA CELL; CELL ACTIVATION; COLORECTAL CARCINOMA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE NUMBER; GENETIC VARIABILITY; HUMAN; HUMAN CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY;

CELL ADHESION; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; E-SELECTIN; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA, MESSENGER; UP-REGULATION;

EID: 50549095224     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23375     Document Type: Article

References (54)

1. Vestweber D. Regulation of endothelial cell contacts during leukocyte extravasation. Curr Opin Cell Biol 2002;14:587-93.
2. Ley K. The role of selectins in inflammation and disease. Trends Mol Med 2003;9:263-8.
3. Witz IP. Tumor-microenvironment interactions: the selectin-selectin ligand axis in tumor-endothelium cross talk. Cancer Treat Res 2006;130:125-40.
4. Voura EB, Sandig M, Siu CH. Cell-cell interactions during transendothelial migration of tumor cells. Microsc Res Tech 1998;43:265-75.
5. Renkonen R, Mattila P, Majuri ML, Rabina J, Toppila S, Renkonen J, Hirvas L, Niittymaki J, Turunen JP, Renkonen O, Paavonen T. In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands. Glycoconj J 1997;14:593-600.
6. Kim YJ, Borsig L, Han HL, Varki NM, Varki A. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 1999;155:461-72.
7. Ito K, Ye CL, Hibi K, Mitsuoka C, Kannagi R, Hidemura K, Ando H, Kasai Y, Akiyama S, Nakao A. Paired tumor marker of soluble E-selectin and its ligand sialyl Lewis A in colorectal cancer. J Gastroenterol 2001;36:823-9.
8. Laferriere J, Houle F, Taher MM, Valerie K, Huot J. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem 2001;276:33762-72.
9. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K. Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 2003;284:C977-C987.
10. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 2004;95:377-84.
11. Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 2004;64:5261-9.
12. Ohrlein R. Carbohydrates and derivatives as potential drug candidates with emphasis on the selectin and linear-B area. Mini Rev Med Chem 2001;1:349-61.
13. Insug O, Otvos L, Kieber-Emmons T, Blaszczyk-Thurin M. Role of SA-Le(a) and E-selectin in metastasis assessed with peptide antagonist. Peptides 2002;23:999-1010.
14. Mathieu S, Prorok M, Benoliel AM, Uch R, Langlet C, Bongrand P, Gerolami R, El-Battari A. Transgene expression of α(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin. Am J Pathol 2004;164:371-83.
15. Hiramatsu Y, Moriyama H, Kiyoi T, Tsukida T, Inoue Y, Kondo H. Studies on selectin blockers. VI. Discovery of homologous fucose sugar unit necessary for E-selectin binding. J Med Chem 1998;41:2302-7.
16. Haroun-Bouhedja F, Lindenmeyer F, Lu H, Soria C, Jozefonvicz J, Boisson-Vidal C. In vitro effects of fucans on MDA-MB231 tumor cell adhesion and invasion. Anticancer Res 2002;22:2285-92.
17. Nubel T, Dippold W, Kleinen H, Kaina B, Fritz G. Lovastatin inhibits Rho-regulated expression of E-selectin by TNFα and attenuates tumor cell adhesion. FASEB J 2004;18:140-2.
18. Shirahama T, Ikoma M, Muramatsu T, Kayajima T, Ohi Y, Tsushima T, Akebi N, Ohmori H, Hirao Y, Okajima E. The binding site for fucose-binding proteins of Lotus tetragonolobus is a prognostic marker for transitional cell carcinoma of the human urinary bladder. Cancer 1993;72:1329-34.
19. Izumi Y, Taniuchi Y, Tsuji T, Smith CW, Nakamori S, Fidler IJ, Irimura T. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Exp Cell Res 1995;216:215-21.
20. Thurin M, Kieber-Emmons T. SA-Lea and tumor metastasis: the old prediction and recent findings. Hybrid Hybridomics 2002;21:111-16.
21. Magnani JL. The discovery, biology, and drug development of sialyl Lea and sialyl Lex. Arch Biochem Biophys 2004;426:122-31.
22. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999;79:181-213.
23. Kaplanski G, Farnarier C, Benoliel AM, Foa C, Kaplanski S, Bongrand P. A novel role for E- and P-selectins: shape control of endothelial cell monolayers. J Cell Sci 1994;107(Part 9):2449-57.
24. Yoshida M, Szente BE, Kiely JM, Rosenzweig A, Gimbrone MA, Jr. Phosphorylation of the cytoplasmic domain of E-selectin is regulated during leukocyte-endothelial adhesion. J Immunol 1998;161:933-41.
25. Simon SI, Cherapanov V, Nadra I, Waddell TK, Seo SM, Wang Q, Doerschuk CM, Downey GP. Signaling functions of L-selectin in neutrophils: alterations in the cytoskeleton and colocalization with CD18. J Immunol 1999;163:2891-901.
26. Kiely JM, Hu Y, Garcia-Cardena G, Gimbrone MA Jr. Lipid raft localization of cell surface E-selectin is required for ligation-induced activation of phospholipase Cγ. J Immunol 2003;171:3216-24.
27. Soltesz SA, Powers EA, Geng JG, Fisher C. Adhesion of HT-29 colon carcinoma cells to E-selectin results in increased tyrosine phosphorylation and decreased activity of c-src. Int J Cancer 1997;71:645-53.
28. Laferriere J, Houle F, Huot J. Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2/p38. Ann N Y Acad Sci 2002;973:562-72.
29. Tremblay PL, Auger FA, Huot J. Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 2006;25:6563-73.
30. Gout S, Morin C, Houle F, Huot J. Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 2006;66:9117-24.
31. Blanks JE, Moll T, Eytner R, Vestweber D. Stimulation of P-selectin glycoprotein ligand-1 on mouse neutrophils activates β 2-integrin mediated cell attachment to ICAM-1. Eur J Immunol 1998;28:433-43.
32. Zipin A, Israeli-Amit M, Meshel T, Sagi-Assif O, Yron I, Lifshitz V, Bacharach E, Smorodinsky NI, Many A, Czernilofsky PA, Morton DL, Witz IP. Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells. Cancer Res 2004;64:6571-8.
33. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988;48:6863-71.
34. Eshel R, Besser M, Zanin A, Sagi-Assif O, Witz IP. The FX enzyme is a functional component of lymphocyte activation. Cell Immunol 2001;213:141-8.
35. Ferre F. Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Appl 1992;2:1-9.
36. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003;4:P3.
37. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003;4:R70.
38. Alfarano C, Andrade CE, Anthony K, Bahroos N, Bajec M, Bantoft K, Betel D, Bobechko B, Boutilier K, Burgess E, Buzadzija K, Cavero R, et al. The biomolecular interaction network database and related tools 2005 update. Nucleic Acids Res 2005;33:D418-D424.
39. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999;71:435-78.
40. Turner CE. Paxillin interactions. J Cell Sci 2000;113(Part 23):4139-40.
41. Beckerich JM, Boisrame-Baudevin A, Gaillardin C. Yarrowia lipolytica: a model organism for protein secretion studies. Int Microbiol 1998;1:123-30.
42. Jayaraman L, Moorthy NC, Murthy KG, Manley JL, Bustin M, Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev 1998;12:462-72.
43. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a nonclassical, vesicle-mediated secretory pathway. EMBO Rep 2002;3:995-1001.
44. Sagt CM, Kleizen B, Verwaal R, de Jong MD, Muller WH, Smits A, Visser C, Boonstra J, Verkleij AJ, Verrips CT. Introduction of an N-glycosylation site increases secretion of heterologous proteins in yeasts. Appl Environ Microbiol 2000;66:4940-4.
45. Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H, Tracey KJ, Andersson J, Palmblad JE. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003;254:375-85.
46. Narita T, Kawakami-Kimura N, Kasai Y, Hosono J, Nakashio T, Matsuura N, Sato M, Kannagi R. Induction of E-selectin expression on vascular endothelium by digestive system cancer cells. J Gastroenterol 1996;31:299-301.
47. Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S, Brodt P. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 1999;59:1356-61.
48. Eshel R, Neumark E, Sagi-Assif O, Witz IP. Receptors involved in microenvironment-driven molecular evolution of cancer cells. Semin Cancer Biol 2002;12:139-47.
49. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004;255:320-31.
50. Erlandsson Harris H, Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 2004;34:1503-12.
51. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005;5:331-42.
52. Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, Susarla S, Ulloa L, Yang H, Fan S, Goyert SM, Wang P, Tracey KJ, et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14-and TNF-dependent mechanisms. J Leukoc Biol 2004;76:994-1001.
53. Schlueter C, Weber H, Meyer B, Rogalla P, Roser K, Hauke S, Bullerdiek J. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 2005;166:1259-63.
54. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-17.